• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ibrutinib does not reverse disease- and treatment-related hypogammaglobulinaemia associated with chronic lymphocytic leukemia.

作者信息

Khan Sujoy, Durairaj Senthilkumar, Phumphukhieo Punyarat, Holding Stephen, Allsup David

机构信息

Immunology and Allergy, Castle Hill Hospital, Hull University Teaching Hospitals NHS Trust, Cottingham, UK.

Department of Haemato-Oncology, Castle Hill Hospital, Hull University Teaching Hospitals NHS Trust, Cottingham, UK.

出版信息

Leuk Lymphoma. 2021 Jul;62(7):1786-1789. doi: 10.1080/10428194.2021.1885662. Epub 2021 Feb 17.

DOI:10.1080/10428194.2021.1885662
PMID:33596758
Abstract
摘要

相似文献

1
Ibrutinib does not reverse disease- and treatment-related hypogammaglobulinaemia associated with chronic lymphocytic leukemia.依鲁替尼不能逆转与慢性淋巴细胞白血病相关的疾病及治疗相关的低丙种球蛋白血症。
Leuk Lymphoma. 2021 Jul;62(7):1786-1789. doi: 10.1080/10428194.2021.1885662. Epub 2021 Feb 17.
2
Infection with ibrutinib in patients with chronic lymphocytic leukemia: How strong is the association?依鲁替尼治疗慢性淋巴细胞白血病患者的感染情况：关联有多强？
Eur J Haematol. 2018 Sep;101(3):418-420. doi: 10.1111/ejh.13098. Epub 2018 Jun 22.
3
Natural history of noninfectious, ibrutinib-attributable adverse events in patients with chronic lymphocytic leukemia.慢性淋巴细胞白血病患者中与依鲁替尼相关的非感染性不良事件的自然病程
Leuk Lymphoma. 2021 Mar;62(3):716-721. doi: 10.1080/10428194.2020.1838508. Epub 2020 Nov 19.
4
Trisomy 12 is associated with an abbreviated redistribution lymphocytosis during treatment with the BTK inhibitor ibrutinib in patients with chronic lymphocytic leukaemia.在慢性淋巴细胞白血病患者中，使用布鲁顿酪氨酸激酶（BTK）抑制剂依鲁替尼治疗期间，12号染色体三体与淋巴细胞再分布缩短相关。
Br J Haematol. 2015 Jul;170(1):125-8. doi: 10.1111/bjh.13269. Epub 2014 Dec 18.
5
Comparative Analysis of Risk Prediction Scores for Treatment-Emergent Atrial Fibrillation Among Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib.依鲁替尼治疗的慢性淋巴细胞白血病患者治疗中出现房颤的风险预测评分的比较分析
Am J Ther. 2024;31(4):e453-e455. doi: 10.1097/MJT.0000000000001666. Epub 2024 Feb 2.
6
Recurrent Uveitis Related to Ibrutinib for Treatment of Chronic Lymphocytic Leukemia.与伊布替尼治疗慢性淋巴细胞白血病相关的复发性葡萄膜炎。
Ocul Immunol Inflamm. 2022 May 19;30(4):1005-1008. doi: 10.1080/09273948.2020.1841802. Epub 2021 Feb 4.
7
Four-Factor Score for Outcome of Ibrutinib Treatment in Chronic Lymphocytic Leukemia: Prognostic Model for Risk Group Definition.
J Clin Oncol. 2021 Feb 20;39(6):551-553. doi: 10.1200/JCO.20.02685. Epub 2020 Oct 13.
8
Malakoplakia of the Urinary Bladder in a Patient with Chronic Lymphocytic Leukemia Under Ibrutinib Therapy: A Case Report.接受依鲁替尼治疗的慢性淋巴细胞白血病患者发生膀胱软斑病：一例报告
Anticancer Res. 2016 Sep;36(9):4759-62. doi: 10.21873/anticanres.11032.
9
Bilateral cystoid macular edema in a patient with chronic lymphocytic leukemia treated with ibrutinib.一名接受依鲁替尼治疗的慢性淋巴细胞白血病患者出现双侧黄斑囊样水肿。
Leuk Lymphoma. 2019 Mar;60(3):842-844. doi: 10.1080/10428194.2018.1508673. Epub 2018 Sep 6.
10
Progressive multi-focal leucoencephalopathy among ibrutinib-treated persons with chronic lymphocytic leukaemia.依鲁替尼治疗的慢性淋巴细胞白血病患者中的进行性多灶性白质脑病
Br J Haematol. 2018 Jan;180(2):301-304. doi: 10.1111/bjh.14322. Epub 2016 Sep 21.